Next-Generation Sequencing to Detect Minimal Residual Disease in AML | Genetics and Genomics | JAMA | The JAMA Network

Next-Generation Sequencing to Detect Minimal Residual Disease in AML | Genetics and Genomics | JAMA | The JAMA Network

Next-Generation Sequencing and Detection of Minimal Residual Disease in Acute Myeloid LeukemiaReady for Clinical Practice?

Friederike Pastore, MD¹; Ross L. Levine, MD^1,2

Author Affiliations

JAMA. 2015;314(8):778-780. doi:10.1001/jama.2015.9452